Urgent

Erythema multiforme (minor & major)

erythema multiforme, EM, target lesions, EM major, EM minor, HSV-associated erythema multiforme, Mycoplasma · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Acute, often recurrent, immune-mediated reaction with characteristic typical target lesions (3 zones) on the extremities/acral sites. Most commonly triggered by herpes simplex virus (and Mycoplasma pneumoniae in children); drugs are a less common trigger than in SJS. EM major has mucosal involvement. It is distinct from SJS/TEN (which is drug-induced with central-to-truncal atypical targets, epidermal detachment and higher mortality).

Figures & algorithms

Target lesions
Target lesions

Red flags

  • Truncal distribution, atypical flat targets, skin pain, Nikolsky-positive detachment, blistering >10% BSA - this is SJS/TEN, not EM - escalate
  • Extensive mucosal involvement limiting eating/drinking
  • Ocular involvement - risk of scarring/symblepharon (urgent ophthalmology)
  • Systemic toxicity / high fever / organ involvement
  • Rapidly progressive or recurrent severe disease

Assessment

Differential diagnosis

  • Stevens-Johnson syndrome / TEN (drug-induced, truncal atypical targets, skin detachment, sicker)
  • Urticaria / urticarial vasculitis (lesions fixed >24 h, target vs)
  • Fixed drug eruption
  • Mycoplasma-induced rash and mucositis (MIRM)
  • Acute febrile neutrophilic dermatosis (Sweet's)
  • Bullous pemphigoid (urticarial phase)
  • Vasculitis
  • Kawasaki disease (children)

Investigations

  • Clinical diagnosis - typical target lesions, acral/extensor distribution, assess mucosae
  • Identify trigger: history of recent/recurrent herpes labialis; in children/atypical - Mycoplasma serology/PCR and CXR; drug history
  • Bloods if systemically unwell / EM major: FBC, U&E, LFTs, CRP
  • HSV PCR of lesion if diagnostic doubt; swab mucosal lesions
  • Skin biopsy if diagnosis unclear or to differentiate from SJS/TEN
  • Ophthalmology review if ocular mucosal involvement

Management

  • Confirm EM and distinguish from SJS/TEN (truncal atypical targets + skin detachment + mucosal necrosis = SJS/TEN, a different pathway - see SJS/TEN protocol)
  • Identify and treat trigger: aciclovir if active HSV; macrolide/appropriate antibiotic if Mycoplasma; stop any culprit drug
  • EM minor (no/limited mucosal, well patient): symptomatic - topical steroid, oral antihistamine, analgesia; self-limiting over ~2 weeks
  • EM major (significant mucosal involvement): supportive care - oral/ophthalmic/genital mucosal care, hydration, analgesia, nutrition; admit if unable to eat/drink or eyes involved
  • Ophthalmology, oral care and urology/gynae input for mucosal disease
  • Consider short course systemic corticosteroid for severe symptomatic mucosal EM major (specialist, evidence limited)
  • Recurrent HSV-associated EM: continuous suppressive aciclovir/valaciclovir for 6-12 months

Drugs & doses

Aciclovir 400 mg ORAL five times daily for active HSV-triggered EM; or valaciclovir 1 g twice daily [verify local dose]
Recurrent HSV-associated EM: aciclovir 400 mg ORAL twice daily (or valaciclovir 500 mg twice daily) continuous suppression for 6-12 months [verify local dose]
Mycoplasma: azithromycin or doxycycline per age/local guidance [verify local dose]
Topical corticosteroid (moderate-potent) for cutaneous lesions + oral antihistamine for itch
Mucosal care: antiseptic/anaesthetic mouthwash (e.g. benzydamine, or lidocaine + chlorhexidine), soft diet
Prednisolone 0.5-1 mg/kg/day ORAL short tapering course for severe EM major mucosal disease - specialist, controversial [verify local dose]
Analgesia and IV fluids if unable to maintain oral intake

Disposition

EM minor: discharge with trigger treatment and symptomatic care. EM major / unable to eat-drink / ocular involvement: admit with dermatology, ophthalmology and mucosal-care input. Any suspicion of SJS/TEN: manage per SJS/TEN protocol (burns/HDU).

Complications & pitfalls

  • Recurrence (HSV-driven)
  • Mucosal scarring and ocular sequelae (symblepharon, vision loss) in EM major
  • Secondary infection of eroded skin/mucosa
  • Dehydration/malnutrition from oral disease
  • Post-inflammatory pigmentation

Exam pearls

  • Typical targets (3 concentric zones) on acral/extensor sites with a well patient = EM; central truncal atypical targets with skin detachment and a sick patient = SJS/TEN (different cause, prognosis and pathway)
  • HSV is the commonest trigger - ask about cold sores; Mycoplasma in children (think MIRM with prominent mucositis and sparse skin)
  • Drugs cause SJS/TEN far more than EM - do not over-attribute EM to drugs
  • Recurrent EM = give suppressive antiviral even without visible herpes
  • Mucosal EM major needs ophthalmology and multidisciplinary mucosal care

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.